SERA
Sera Prognostics, Inc.
SERA lost money over the past year, so it has no meaningful PE right now.
SERA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
SERA's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
SERA PE Valuation
SERA has no meaningful PE right now: it lost money over the past year.
SERA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect SERA's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
SERA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.66 | +$0.11 |
| Q2 2026 | -$0.66 | +$0.19 |
| Q1 2026 | -$0.64 | +$0.30 |
| Q4 2025 | -$0.67 | +$0.32 |
| Q3 2025 | -$0.77 | +$0.22 |
| Q2 2025 | -$0.85 | +$0.13 |
| Q1 2025 | -$0.94 | +$0.13 |
| Q4 2024 | -$0.99 | +$0.17 |
SERA is still losing money, but far less than before: $0.66 per share over the past year, against $1.43 at its worst in late 2022.
SERA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42K | +163% |
| Q2 2026 | $30K | +76% |
| Q1 2026 | $14K | -63% |
| Q4 2025 | $10K | -58% |
| Q3 2025 | $16K | -45% |
| Q2 2025 | $17K | -29% |
| Q4 2024 | $24K | -41% |
| Q3 2024 | $29K | -31% |
SERA's revenue is recovering but still below its 2023 peak: $42,000 last quarter, up 163% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -21160% | +34966 points |
| Q2 2026 | -33347% | +21477 points |
| Q1 2026 | -66857% | -42515 points |
| Q4 2025 | -89540% | -50278 points |
| Q3 2025 | -56125% | -25566 points |
| Q2 2025 | -54824% | -16269 points |
| Q1 2025 | -24342% | N/A |
| Q4 2024 | -39263% | -17682 points |
SERA's operating margin was −21160% last quarter, up 34965 points from the same quarter a year ago.
SERA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.4M | -$843K |
| Q2 2026 | -$6.3M | -$573K |
| Q1 2026 | -$8.8M | -$1.2M |
| Q4 2025 | -$6.5M | -$182K |
| Q3 2025 | -$6.6M | +$432K |
| Q2 2025 | -$5.8M | +$181K |
| Q1 2025 | -$7.6M | -252% |
| Q4 2024 | -$6.3M | +$513K |
SERA has burned cash in almost every quarter: −$29M over the past year, against −$26M the year before.
SERA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +313K shares |
| 1 year | +2.6% | +1.3M shares |
| 3 years | +62% | +19.5M shares |
| 5 years | +66% | +20.3M shares |
| Available history | +180% | +32.7M shares |
SERA has 51M diluted shares, up 2.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
SERA Net Leverage
SERA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SERA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.5 | Neutral |
| Stochastic | 57.3 | Neutral |
SERA's weekly RSI is 46 (neutral) and its Stochastic is 57 (neutral).
SERA PE vs Healthcare Sector
SERA has no meaningful PE right now: it lost money over the past year.
SERA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.06 | 3.9% below |
| 20 week MA | $2.05 | 3.4% below |
| 50 week MA | $2.29 | 14% below |
| 100 week MA | $2.97 | 33% below |
| 200 week MA | $4.19 | 53% below |
SERA is in a downtrend: it's below all five of its weekly moving averages, and 53% below its 200-week average.
SERA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $11.0 | $8.00 | -27% |
| 2022 | $8.00 | $1.60 | -80% |
| 2023 | $1.60 | $5.98 | +274% |
| 2024 | $5.98 | $8.00 | +34% |
| 2025 | $8.00 | $3.52 | -56% |
| 2026 YTD | $3.52 | $1.98 | -44% |
SERA's yearly returns have swung widely, from +274% in 2023 to −80% in 2022. It's down 44% so far in 2026.